1. Unit startpage
  2. Employees
  3. Gunnstein Bakland
No picture, placeholder image
No picture, placeholder image
Førsteamanuensis Klinihkalaš medisiinna instituhtta gunnstein.bakland@uit.no

Gunnstein Bakland

  • pål Nicolay Rydning, Hege Linnerud, JALAL MIRZAMOHAMMADI, Tor Brommeland, Pål Andre Rønning, Magnus Mejlænder-Evjensvold et al.:
    Decreasing incidence of cervical spine fractures in patients with ankylosing spondylitis: a population-based study in Southeast Norway
    The spine journal 2024 DOI
  • Sella Aarrestad Provan, F. Ahlfors, Gunnstein Bakland, Yi Hu, Eirik Kristianslund, Eirik Ikdahl et al.:
    A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study
    Scandinavian Journal of Rheumatology 2024 DOI
  • Gudrun David Sigmo, Solveig Hauge, Karl Ove Hufthammer, Marianne Wallenius, Kjell Åsmund Blix Salvesen, Anne Kjersti Nesje Daltveit et al.:
    Male patients with inflammatory joint diseases are less likely than controls to be childless: Results from a Norwegian population-based cohort study of 10 865 patients
    Annals of the Rheumatic Diseases 2024 ARKIV / DOI
  • Katarzyna Weronika Łosińska, Are Hugo Pripp, Gunnstein Bakland, Bjørg Tilde Svanes Fevang, Lene Kristin Brekke, Ada Wierød et al.:
    Comparative Effectiveness and Persistence of SB4 and Reference Etanercept in Patients With Psoriatic Arthritis in Norway
    Arthritis care & research 2024 ARKIV / DOI
  • Kaja Eriksrud Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Hallvard Fremstad et al.:
    Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial
    The Lancet Rheumatology 2024 DOI
  • Emil E. Kvernberg Thomassen, Inger Jorid Berg, Eirik Kristianslund, Anne Therese Tveter, Gunnstein Bakland, Laure Gossec et al.:
    Patients with axial spondyloarthritis reported willingness to use remote care and showed high adherence to electronic patient-reported outcome measures: an 18-month observational study
    Rheumatology International 2024 ARKIV / DOI
  • Mielnik Pawel, Joseph Sexton, Karen Minde Fagerli, Gunnstein Bakland, Yi Hu, Eirik Kristianslund et al.:
    Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD)
    Rheumatology - Advances in Practice (Rheumap) 2023 ARKIV / DOI
  • Anne Christine Bull Haaversen, Lene Kristin Brekke, Gunnstein Bakland, Erik Rødevand, Geirmund Myklebust, Andreas P Diamantopoulos :
    Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis
    Frontiers in medicine 2023 ARKIV / DOI
  • Alen Brkic, Andreas P Diamantopoulos, Mari Hoff, Espen A. Haavardsholm, Bjørg Tilde Svanes Fevang, Lene Kristin Brekke et al.:
    Exploring the impact of the national tender system on the use of costly drugs treating rheumatoid arthritis patients in ten rheumatology centers in Norway (2010–2019)
    BMC Health Services Research 2023 ARKIV / DOI
  • Glenn Haugeberg, Gunnstein Bakland, Erik Rødevand, Inger Johanne Widding Hansen, Andreas P Diamantopoulos, Are Hugo Pripp :
    Effectiveness and Persistence in SB4- and Reference Etanercept–Treated Rheumatoid Arthritis Patients in Ordinary Clinical Practice in Norway
    Arthritis care & research 2023 ARKIV / DOI
  • Jens Vikse, Øyvind Midtvedt, Bjørg Tilde Svanes Fevang, Torhild Oddveig Garen, Øyvind Palm, Marianne Wallenius et al.:
    Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort
    Arthritis Research & Therapy 2023 ARKIV / DOI
  • Mikkel Østergaard, Ronald F Van Vollenhoven, Anna Rudin, Merete Lund Hetland, Marte Schrumpf, Dan C Nordström et al.:
    Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
    Annals of the Rheumatic Diseases 09. Jul 2023 FULLTEKST / ARKIV / DOI
  • Inger Jorid Berg, Anne Therese Tveter, Gunnstein Bakland, Sarah Hakim, Eirik Kristianslund, Siri Lillegraven et al.:
    Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial
    JMIR Research Protocols 2023 ARKIV / DOI
  • Siri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Åse Lexberg et al.:
    Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial
    Annals of the Rheumatic Diseases 22. Aug 2023 ARKIV / FULLTEKST / DOI
  • Alen Brkic, Andreas P Diamantopoulos, Espen A. Haavardsholm, Bjørg Tilde Svanes Fevang, Lene Kristin Brekke, Liz Paucar Loli et al.:
    Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010–2019 – a country with a national tender system for prescription of costly drugs
    BMC Health Services Research 2022 ARKIV / DOI
  • Magnhild Hammersland Dagestad, Nils Vetti, Per M Kristoffersen, John Anker Henrik Zwart, Kjersti Storheim, Gunnstein Bakland et al.:
    Apparent diffusion coefficient values in Modic changes – interobserver reproducibility and relation to Modic type
    BMC Musculoskeletal Disorders 2022 ARKIV / DOI
  • Imane Bardan, Karen Minde Fagerli, Joseph Sexton, Tore Kristian Aaserud Kvien, Gunnstein Bakland, Mielnik Pawel et al.:
    Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD
    Journal of Rheumatology 2022 ARKIV / DOI
  • Ingrid Egeland Christensen, Siri Lillegraven, Mielnik Pawel, Gunnstein Bakland, Liz Paucar Loli, Joseph Sexton et al.:
    Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study
    Annals of the Rheumatic Diseases 2021 ARKIV / DOI
  • Siri Lillegraven, Nina Beate Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Hallvard Fremstad et al.:
    Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients with Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial
    Journal of the American Medical Association (JAMA) 04. May 2021 FULLTEKST / DOI
  • Anna-Maria Hoffmann-Vold, Håvard Halland Fretheim, Vikas Kumar Sarna, Imon Shoumitra Barua, Maylen Carstens Nordgård, Oliver Distler et al.:
    Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: Study protocol for the randomised controlled phase II ReSScue trial
    BMJ Open 2021 ARKIV / DOI
  • Christian Bindesbøll, Marco Garrido-Cumbrera, Gunnstein Bakland, Hanne Dagfinrud :
    Obesity Increases Disease Activity of Norwegian Patients with Axial Spondyloarthritis: Results from the European Map of Axial Spondyloarthritis Survey
    Current Rheumatology Reports 2020 DOI
  • Mielnik Pawel, Joseph Sexton, Elisabeth Lie, Gunnstein Bakland, Liz Paucar Loli, Eirik Kristianslund et al.:
    Does Older Age have an Impact on Rituximab Efficacy and Safety? Results from the NOR-DMARD Register
    Drugs & Aging 2020 DOI
  • Merete Lund Hetland, Espen A. Haavardsholm, Anna Rudin, Dan C. Nordström, Michael Nurmohamed, Bjorn Gudbjornsson et al.:
    Active conventional treatment and three different biological treatments in early rheumatoid arthritis: Phase IV investigator initiated, randomised, observer blinded clinical trial
    The BMJ 2020 ARKIV / FULLTEKST / DOI
  • Aksel Thuv Nilsen, Christine Karlsen, Gunnstein Bakland, Richard Watts, Raashid Luqmani, Wenche Koldingsnes :
    Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway
    Rheumatology 2020 DOI
  • Elisabeth Gjefsen, Lars Christian Haugli Bråten, Guro Løvik Goll, Monica Wigemyr, Nils Bolstad, Morten Valberg et al.:
    The effect of infliximab in patients with chronic low back pain and Modic changes (the BackToBasic study): study protocol of a randomized, double blind, placebo-controlled, multicenter trial
    BMC Musculoskeletal Disorders 21. Oct 2020 ARKIV / DOI
  • Brigitte Michelsen, Joseph Sexton, Ada Wierød, Gunnstein Bakland, Erik Rødevand, Frode Krøll et al.:
    Four-year follow-up of inflammatory arthropathy patients treated with golimumab: Data from the observational multicentre NOR-DMARD study
    Seminars in Arthritis & Rheumatism 2019 DOI
  • Johannes Nossent, Sylvia Sagen Johnsen, Gunnstein Bakland :
    Disease Activity and Patient-Reported Health Measures in Relation to Cytokine Levels in Ankylosing Spondylitis
    Rheumatology and therapy 2019 DOI
  • Hege Lynum Pedersen, Kjersti Daae Horvei, Dhivya Thiyagarajan, Gudrun Norby, Natalya Seredkina, Gabriella Moroni et al.:
    Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression
    The journal of pathology. Clinical research 2018 ARKIV / DOI
  • Vibeke Norvang, Joseph Sexton, Eirik Kristianslund, Inge Christoffer Olsen, Till Uhlig, Gunnstein Bakland et al.:
    Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study
    RMD Open 2018 ARKIV / DOI
  • Eirik Ikdahl, Grunde Wibetoe, Silvia Christin Hellerud Rollefstad, Anne Salberg, Kjetil Bergsmark, Tore Kristian Kvien et al.:
    Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases
    International Journal of Cardiology 2018 DOI
  • Seyed Esmaeil Dorraji, Aud-Malin Karlsson Hovd, Premasany Kanapathippillai, Gunnstein Bakland, Gro Østli Eilertsen, Stine Figenschau et al.:
    Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis
    Scientific Reports 2018 ARKIV / DOI
  • Grunde Wibetoe, Eirik Ikdahl, Silvia Christin Hellerud Rollefstad, Inge Christoffer Olsen, Kjetil Bergsmark, Tore Kristian Kvien et al.:
    Discrepancies in risk age and relative risk estimations of cardiovascular disease in patients with inflammatory joint diseases
    International Journal of Cardiology 2018 DOI
  • Eirik Ikdahl, Silvia Christin Hellerud Rollefstad, Grunde Wibetoe, Anne Salberg, Frode Krøll, Kjetil Bergsmark et al.:
    Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: Experiences from the nationwide NOCAR project
    RMD Open 2018 DOI
  • Julianne Elvenes, Silje Fismen, Gunn-Marit Lynghaug, Gunnstein Bakland :
    A patient with spondylarthropathy treated with TNF-? inhibitors presenting with clinical findings suspicious of metastatic cancer disease
    Rheumatology 2018 DOI
  • Gina Charlotte Hetland Brinkmann, Vibeke Norvang, Ellen Sauar Norli, Lars Grøvle, Anne Julsrud Haugen, Åse Lexberg et al.:
    Treat to target strategy in early rheumatoid arthritis versus routine care – A comparative clinical practice study
    Seminars in Arthritis & Rheumatism 2018 DOI
  • Brigitte Michelsen, Till Uhlig, Joseph Sexton, Desirée van der Heijde, Hilde Berner Hammer, Eirik Kristianslund et al.:
    Health-related quality of life in patients with psoriatic and rheumatoid arthritis: Data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls
    Annals of the Rheumatic Diseases 2018 ARKIV / DOI
  • Johannes C. Nossent, Sylvia Sagen-Johnsen, Gunnstein Bakland :
    IL23R gene variants in relation to IL17A levels and clinical phenotype in patients with ankylosing spondylitis
    Rheumatology - Advances in Practice (Rheumap) 2018 DOI
  • Grunde Wibetoe, Eirik Ikdahl, Silvia Christin Hellerud Rollefstad, Inge Christoffer Olsen, Kjetil Bergsmark, Tore Kristian Kvien et al.:
    Cardiovascular disease risk profiles in inflammatory joint disease entities
    Arthritis Research & Therapy 2017 DOI
  • Jens Vikse, Even Lillejordet, Karen Minde Fagerli, Gunnstein Bakland, Espen A. Haavardsholm :
    Spondyloartritt: en oversikt
    Universitetsforlaget 2024
  • Jens Vikse, Gunnstein Bakland, Inger Jorid Berg, Espen A. Haavardsholm :
    Aksial spondyloartritt
    Universitetsforlaget 2024
  • Mikkel Østergaard, Ronald van Vollenhoven, Anna Rudin, Merete L. Hetland, Marte Schrumpf, Dan Nordström et al.:
    CERTOLIZUMAB-PEGOL, ABATACEPT, TOCILIZUMAB OR ACTIVE CONVENTIONAL THERAPY IN EARLY RHEUMATOID ARTHRITIS: CLINICAL AND RADIOGRAPHIC 48-WEEKS RESULTS OF THE INVESTIGATOR-INITIATED RANDOMIZED NORD-STAR TRIAL
    Annals of the Rheumatic Diseases 23. May 2022 FULLTEKST
  • Siri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joe Sexton, Inge Christoffer Olsen, Hallvard Fremstad et al.:
    Drug Free Remission in Rheumatoid Arthritis: Data from the Randomized Controlled ARCTIC REWIND Trial
    Arthritis & Rheumatology 2022 DOI
  • Siri Lillegraven, Nina Beate Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Åse Lexberg et al.:
    STABLE VERSUS TAPERED AND WITHDRAWN TREATMENT WITH TUMOR NECROSIS FACTOR INHIBITOR IN RHEUMATOID ARTHRITIS REMISSION (ARCTIC REWIND): A RANDOMISED, OPEN-LABEL, PHASE 4, NON-INFERIORITY TRIAL
    Annals of the Rheumatic Diseases 2020 FULLTEKST / DOI
  • Siri Lillegraven, Nina Beate Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Hallvard Fremstad et al.:
    TAPERING OF CONVENTIONAL SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN SUSTAINED RHEUMATOID ARTHRITIS REMISSION: RESULTS FROM A RANDOMIZED CONTROLLED TRIAL
    Annals of the Rheumatic Diseases 2020 FULLTEKST / DOI
  • Hege Lynum Pedersen, Kjersti Daae Horvei, Dhivya Thiyagarajan, Gudrun Norby, Natalya Seredkina, Gabriella Moroni et al.:
    LUPUS NEPHRITIS: SEVERELY REDUCED URINARY DNASE I LEVELS REFLECT LOSS OF RENAL DNASE I, DISEASE PROGRESSION AND MAY REDUCE THE NEED FOR RENAL BIOPSIES
    2018
  • Inger Myrnes Hansen, Gunnstein Bakland :
    DISEASE ACTIVITY AND CHARACTERISTICS OF SpA-PATIENTS FULFILLING ESSG CRITERIA ONLY COMPARED TO SpAPATIENTS FULFILLING ASAS CRITERIA
    Clinical and Experimental Rheumatology 2018
  • Inger Myrnes Hansen, Gunnstein Bakland :
    Patients fulfilling European Spondyloarthropathy Study Group (ESSG) criteria but not Assessment of SpondyloArthritis international Society (ASAS) criteria for spondylarthritis
    Scandinavian Journal of Rheumatology 2018 DOI
  • Espen A. Haavardsholm, Anna-Birgitte Aga, Inge Christoffer Olsen, Siri Lillegraven, Hilde Berner Hammer, Till Uhlig et al.:
    Ultrasound in The Management of Rheumatoid Arthritis: Results from The Randomized Controlled Arctic Trial
    Annals of the Rheumatic Diseases 2016 DOI
  • Inger Myrnes Hansen, Gunnstein Bakland, Øystein Thorleiv Førre :
    PLASMA CALPROTECTIN IN SPA-PATIENTS, A BIOMARKER FOR PERIPHERAL ARTHRITIS
    Annals of the Rheumatic Diseases 2016 DOI
  • Inger Myrnes Hansen, Gunnstein Bakland, Øystein Thorleiv Førre :
    PLASMA CALPROTECTIN IN SPA-PATIENTS, A BIOMARKER FOR PERIPHERAL ARTHRITIS
    Clinical and Experimental Rheumatology 2016

    • The 50 latest publications is shown on this page. See all publications in Cristin here →